Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS: AMPE · Delayed Price · USD
0.496
+0.254 (104.99%)
Apr 19, 2024, 3:47 PM EDT - Market closed
Ampio Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 4.09 | 12.65 | 33.89 | 17.35 | 6.53 | 7.59 | 8.21 | 4.89 | 26.96 | 50.32 | Upgrade
|
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.12 | 0 | 0 | Upgrade
|
| Cash & Cash Equivalents | 4.09 | 12.65 | 33.89 | 17.35 | 6.53 | 7.59 | 8.22 | 5.02 | 26.96 | 50.32 | Upgrade
|
| Cash Growth | -67.68% | -62.67% | 95.39% | 165.55% | -13.89% | -7.73% | 63.84% | -81.39% | -46.43% | 91.26% | Upgrade
|
| Receivables | 0 | 0 | 0.02 | 0.19 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Inventory | 0 | 0 | 1.19 | 0.27 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Assets | 1.65 | 0.68 | 0.53 | 0.7 | 1.72 | 0.41 | 0.22 | 0.38 | 2.27 | 0.94 | Upgrade
|
| Total Current Assets | 5.74 | 13.33 | 35.63 | 18.49 | 8.25 | 8 | 8.44 | 5.4 | 29.23 | 51.26 | Upgrade
|
| Property, Plant & Equipment | 0 | 0.26 | 3.19 | 4.39 | 5.75 | 6 | 6.84 | 7.98 | 9.33 | 9.95 | Upgrade
|
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.22 | 0 | Upgrade
|
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 8.16 | Upgrade
|
| Other Long-Term Assets | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.03 | 0.21 | 0.63 | 0.9 | Upgrade
|
| Total Long-Term Assets | 0 | 0.26 | 3.19 | 4.39 | 5.75 | 6.03 | 6.87 | 8.19 | 21.19 | 19.01 | Upgrade
|
| Total Assets | 5.74 | 13.59 | 38.83 | 22.88 | 14 | 14.03 | 15.31 | 13.6 | 50.42 | 70.27 | Upgrade
|
| Accounts Payable | 0 | 0.1 | 0.43 | 0.19 | 0.15 | 0 | 0 | 0 | 2.88 | 3.3 | Upgrade
|
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.09 | 0.09 | Upgrade
|
| Current Debt | 0.27 | 0.34 | 0.31 | 0.28 | 0.26 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 2.1 | 0.76 | 4.38 | 1.36 | 3.87 | 1.38 | 3.88 | 2.13 | 2.55 | 0.3 | Upgrade
|
| Total Current Liabilities | 2.38 | 1.19 | 5.12 | 1.83 | 4.28 | 1.38 | 3.88 | 2.13 | 5.52 | 3.68 | Upgrade
|
| Long-Term Debt | 0 | 0.27 | 0.61 | 0.93 | 1.21 | 0 | 0 | 0 | 4.92 | 0 | Upgrade
|
| Other Long-Term Liabilities | 0 | 0.33 | 5.81 | 2.61 | 2.06 | 7.41 | 45.61 | 4.83 | 2.05 | 1.13 | Upgrade
|
| Total Long-Term Liabilities | 0 | 0.61 | 6.42 | 3.53 | 3.27 | 7.41 | 45.61 | 4.83 | 6.98 | 1.13 | Upgrade
|
| Total Liabilities | 2.38 | 1.8 | 11.54 | 5.37 | 7.56 | 8.79 | 49.49 | 6.96 | 12.49 | 4.81 | Upgrade
|
| Total Debt | 0.27 | 0.61 | 0.93 | 1.21 | 1.47 | 0 | 0 | 0 | 4.92 | 0 | Upgrade
|
| Debt Growth | -55.37% | -33.62% | -23.49% | -17.70% | - | - | - | - | - | - | Upgrade
|
| Common Stock | 0 | 0 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Retained Earnings | -242.53 | -233.94 | -217.6 | -200.53 | -184.63 | -171 | -204.99 | -153.08 | -133.91 | -101.9 | Upgrade
|
| Comprehensive Income | 0 | 0 | 0 | 0 | 0 | -4.79 | -3.63 | -2.41 | -1.28 | -0.42 | Upgrade
|
| Shareholders' Equity | 3.36 | 11.79 | 27.28 | 17.51 | 6.44 | 5.24 | -34.18 | 6.63 | 37 | 66.12 | Upgrade
|
| Total Liabilities and Equity | 5.74 | 13.59 | 38.83 | 22.88 | 14 | 14.03 | 15.31 | 13.6 | 50.42 | 70.27 | Upgrade
|
| Net Cash / Debt | 3.82 | 12.04 | 32.97 | 16.14 | 5.06 | 7.59 | 8.22 | 5.02 | 22.04 | 50.32 | Upgrade
|
| Net Cash / Debt Growth | -68.31% | -63.48% | 104.30% | 218.66% | -33.24% | -7.73% | 63.84% | -77.23% | -56.21% | 91.26% | Upgrade
|
| Net Cash Per Share | 4.71 | 15.97 | 49.10 | 27.10 | 10.68 | 19.73 | 1.89 | 1.40 | 127.15 | 300.56 | Upgrade
|
| Working Capital | 3.36 | 12.14 | 30.51 | 16.66 | 3.97 | 6.61 | 4.56 | 3.27 | 23.71 | 47.58 | Upgrade
|
| Book Value Per Share | 4.15 | 15.64 | 41.07 | 30.39 | 13.59 | 13.62 | -7.85 | 1.85 | 213.49 | 394.92 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.